Fierce Biotech Week

We invite you to join our session on Tue., May 12 at 1:45 p.m.

Smarter Feasibility: Using AI to Improve Site Selection and Protocol Optimization

Clinical trial feasibility decisions are often made with limited visibility into real-world patient availability, site performance, and investigator expertise.

This session explores how AI and integrated data are helping teams evaluate protocol viability, optimize study design, and identify high-performing sites earlier in the planning process. Through real-world examples, attendees will see how a more data-driven approach to site selection and protocol optimization can support faster study startup and stronger enrollment performance.

Speaker:

Ariel Katz, CEO & Co-founder, H1